Foretinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2018-10, Vol.29, p.viii653-viii653
Hauptverfasser: Yano, S., Nishiyama, A., Kita, K., Takeuchi, S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page viii653
container_issue
container_start_page viii653
container_title Annals of oncology
container_volume 29
creator Yano, S.
Nishiyama, A.
Kita, K.
Takeuchi, S.
description
doi_str_mv 10.1093/annonc/mdy303.012
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy303_012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419502800</els_id><sourcerecordid>S0923753419502800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2302-7b2f04af1a5c6cfe6b0e5edfa96851eecb55622dd2415e4ed23f3376b776b76e3</originalsourceid><addsrcrecordid>eNp9kN1KwzAYhoMobv5cgCeSG-iWnzZd8UiGTnEoiB6XNPmKkTUZSTrY3XippnZ6aOAj38HzvgkPQleUzCip-Fxa66yad3rPCZ8Ryo7QlBaiyhYkp8doSirGs7Lg-QSdhfBJCBEVq07RhDPKy3Sm6OveeYjGmgYr41Xf7cDGgOMH4Oe31yeKV0KUS9z1UUbjbCZDcMrICBon0IP6yWYegglRWgXY2J9042XapNV4Y3bgcQdRJiJAwFvvdK9SQ7M_PNL2YSjfumBionHsO-exgs0mXKCTVm4CXB7uc_R-f_e2fMjWL6vH5e06U4wTlpUNa0kuWyoLJVQLoiFQgG5lJRYFBVBNUQjGtGY5LSAHzXjLeSmachgB_BzRsVd5F4KHtt5600m_rympB9v1aLsebdfJdspcj5lt33Sg_xK_ehNwMwKQfr4z4OugDCRL2gzqau3MP_XfnJqWSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Foretinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yano, S. ; Nishiyama, A. ; Kita, K. ; Takeuchi, S.</creator><creatorcontrib>Yano, S. ; Nishiyama, A. ; Kita, K. ; Takeuchi, S.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy303.012</identifier><identifier>PMID: 32137777</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii653-viii653</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yano, S.</creatorcontrib><creatorcontrib>Nishiyama, A.</creatorcontrib><creatorcontrib>Kita, K.</creatorcontrib><creatorcontrib>Takeuchi, S.</creatorcontrib><title>Foretinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kN1KwzAYhoMobv5cgCeSG-iWnzZd8UiGTnEoiB6XNPmKkTUZSTrY3XippnZ6aOAj38HzvgkPQleUzCip-Fxa66yad3rPCZ8Ryo7QlBaiyhYkp8doSirGs7Lg-QSdhfBJCBEVq07RhDPKy3Sm6OveeYjGmgYr41Xf7cDGgOMH4Oe31yeKV0KUS9z1UUbjbCZDcMrICBon0IP6yWYegglRWgXY2J9042XapNV4Y3bgcQdRJiJAwFvvdK9SQ7M_PNL2YSjfumBionHsO-exgs0mXKCTVm4CXB7uc_R-f_e2fMjWL6vH5e06U4wTlpUNa0kuWyoLJVQLoiFQgG5lJRYFBVBNUQjGtGY5LSAHzXjLeSmachgB_BzRsVd5F4KHtt5600m_rympB9v1aLsebdfJdspcj5lt33Sg_xK_ehNwMwKQfr4z4OugDCRL2gzqau3MP_XfnJqWSw</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Yano, S.</creator><creator>Nishiyama, A.</creator><creator>Kita, K.</creator><creator>Takeuchi, S.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Foretinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells</title><author>Yano, S. ; Nishiyama, A. ; Kita, K. ; Takeuchi, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2302-7b2f04af1a5c6cfe6b0e5edfa96851eecb55622dd2415e4ed23f3376b776b76e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yano, S.</creatorcontrib><creatorcontrib>Nishiyama, A.</creatorcontrib><creatorcontrib>Kita, K.</creatorcontrib><creatorcontrib>Takeuchi, S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yano, S.</au><au>Nishiyama, A.</au><au>Kita, K.</au><au>Takeuchi, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Foretinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii653</spage><epage>viii653</epage><pages>viii653-viii653</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137777</pmid><doi>10.1093/annonc/mdy303.012</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2018-10, Vol.29, p.viii653-viii653
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdy303_012
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Foretinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A25%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Foretinib%20circumvents%20the%20NTRK1%20G667C%20mutation-associated%20entrectinib-resistance%20in%20the%20brain%20and%20liver%20metastases%20produced%20by%20NTRK1%20fusion-positive%20tumor%20cells&rft.jtitle=Annals%20of%20oncology&rft.au=Yano,%20S.&rft.date=2018-10&rft.volume=29&rft.spage=viii653&rft.epage=viii653&rft.pages=viii653-viii653&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy303.012&rft_dat=%3Celsevier_cross%3ES0923753419502800%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137777&rft_els_id=S0923753419502800&rfr_iscdi=true